Skip to main navigation Skip to search Skip to main content

Introduction of typhoid vaccine in the expanded immunization program of Pakistan

  • Fahmida Aslam*
  • , Yang Yue
  • , Majid Aziz
  • *Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

Abstract

Worldwide, typhoid infects 11–20 million people each year. In Pakistan, the first extensively drug-resistant (XDR) typhoid was reported in 2016 resulting in an epidemic. To curb this battle of typhoid, the Expanded Program for Immunization (EPI) of Pakistan requested Global Alliance for Vaccines and Immunization (GAVI) for financial assistance. Hence becoming the first country to administer the vaccination against typhoid in children through EPI. To address the possible risk of endemic, it is needed that WHO and the United Nations should recommend all south Asian countries to avail of this golden opportunity provided by GAVI. Finally, the addition of typhoid vaccine in routine immunization will reduce mortalities, morbidities, health expenditure, and increase life expectancy in all low- and middle-income countries.

Original languageEnglish
Article number2132
JournalHuman Vaccines and Immunotherapeutics
Volume17
Issue number7
DOIs
Publication statusPublished - 31 Jan 2021
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2021 Taylor & Francis Group, LLC.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Antibiotics
  • Epidemic
  • Immunization
  • Typhoid

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Pharmacology

Fingerprint

Dive into the research topics of 'Introduction of typhoid vaccine in the expanded immunization program of Pakistan'. Together they form a unique fingerprint.

Cite this